Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-17 4:34 PM EDT | Cardiol Therapeutics Inc.
Sona Nanotech To Host Investor Webinar To Discuss Clinical Study
Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon EDT to discuss its first-in-human, early feasibility clinical study for its Targeted Hyperthermia Therapy cancer treatment. Ten advanced stage melanoma patients who were failing to respond to standard immunotherapy treatment were recruited into this early feasibility stu
2025-10-17 4:04 PM EDT | Sona Nanotech Inc.
MyndTec Inc. Completes Sixth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 16, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the sixth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The sixth tranche of the private placement consists of 263,428 Units of the Company (the "Units") at a price of $0.20 per Uni
Technology, Healthcare and Hospitals, Health
2025-10-16 6:00 PM EDT | MyndTec Inc.
Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today a major network expansion initiative with the construction of new cellular towers within the proximity of its existing tower network. The Company plans to construct and/or acquire up to 20 new or existing towers/sites by the end of
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-16 4:15 PM EDT | Akanda Corp
El Salvador Emerges as a Prime Investment Destination with Historic Public Safety Gains and Bold Institutional Reforms
San Salvador, El Salvador--(Newsfile Corp. - October 16, 2025) - El Salvador is consolidating its position as a prime investment destination. In 2025, it recorded a remarkable surge in foreign direct investment (FDI) and offered a business environment strengthened by macroeconomic reform, regulatory efficiency, and historic advances in public safety. To build on this momentum, Invest in El Salvador, the country's promotional agency, will lead a U.S. roadshow this month, wi
Auto Manufacturers, Environmental Services, Energy, Health
2025-10-16 3:08 PM EDT | LinkUp Global
Conexeu Sciences Closes Maximum $5M Reg CF Financing
Reno, Nevada--(Newsfile Corp. - October 16, 2025) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a biotechnology company revolutionizing tissue regeneration, is pleased to announce the completion of its $5 million Regulation Crowdfunding (Reg CF) financing. Conexeu secured commitments in excess of $5 million in less than two weeks from the date of launching the financing through the Equifund platform.
Healthcare and Hospitals, Pharmaceuticals, Health
2025-10-16 9:01 AM EDT | Conexeu Sciences Inc.
Mobile-health Network Solutions and Brands For Good Unite to Champion Corporate Wellness and Doing Good
Singapore, Singapore--(Newsfile Corp. - October 16, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a strategic partnership with Brands For Good Ltd ("BFG"), an organization dedicated to recognizing and empowering companies that do good for their communities. According to the partnership, MNDR will provide BFG member companies and their employees with access to corporate wellnes
2025-10-16 8:30 AM EDT | Mobile-health Network Solutions
Cheelcare Appoints Dave Jones as Director of U.S. Sales
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, is pleased to announce the appointment of Dave Jones as Director of U.S. Sales, effective immediately. Mr. Jones brings over 30 years of executive sales and marketing experience in the complex rehabilitation and durable medical equipment (DME) sectors. His career includes senior roles at Drive Medical, Merits Healthcare, Qua
2025-10-16 8:00 AM EDT | Cheelcare Inc.
Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, in Florida under Florida's SB 1768, is pleased to annou
Biotechnology, Pharmaceuticals, Health
2025-10-15 3:51 PM EDT | Hemostemix Inc.
TempraMed to Commence Trading on the Canadian Securities Exchange Under Symbol "VIVI", Today, October 15, 2025
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange ("CSE"). Trading is expected to commence on CSE under symbol "VIVI" at the open of markets on October 15, 2025. Further, the board of directors (the "Board") of the Compa
Technology, Biotechnology, Pharmaceuticals, Health
2025-10-15 7:00 AM EDT | TempraMed Technologies Ltd
Hear At Last Launches HOHM Token for Capital Raise on Solana Blockchain - Now Ready to Trade
Miami, Florida--(Newsfile Corp. - October 14, 2025) - Hear At Last (OTCID: HRAL), a trailblazer in innovative housing solutions, is thrilled to announce the successful launch of its cryptocurrency token, HOHM, on the Solana blockchain. The HOHM token is now live and ready to trade, marking a pivotal step in HRAL's mission to revolutionize affordable housing through blockchain technology. The primary goal of the HOHM token is to raise capital for Hear At Last's ambitious housing i
Household / Consumer / Cosmetics, Health
2025-10-14 11:44 AM EDT | Hear AtLast Holdings, Inc
Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission
Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent public accounting firm and securities counsel to prepare and file its Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC). This filing marks a significant step beyond OTC reporting and positions Adia as a fully reporting public company under the Securities Exchange
Healthcare and Hospitals, Health
2025-10-14 9:00 AM EDT | Adia Nutrition Inc.
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-10-14 8:34 AM EDT | Red Light Holland Corp.
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its growing portfolio, developed to support female fertility and reproductive function in women of advanced maternal age (35+). CBIH believes this innovation should expand evidence-based options for patients and partners. As age is a key determinant of reproductive outcomes—and first births
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-13 7:00 AM EDT | Cannabis Bioscience International Holdings
Numinus Wellness Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, announces that Davidson & Company LLP ("Davidson") has resigned as the Company's independent auditor of its own initiative, and that MNP LLP ("MNP") has been eng
2025-10-10 5:00 PM EDT | Numinus Wellness Inc.
PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all resolutions presented at the Company's annual general and special meeting (the "Meeting") held on Friday, October 10, 2025, including the following: the election of Stephen Van Deventer, Makarand Jawadekar, Kathlee
Biotechnology, Pharmaceuticals, Health
2025-10-10 4:00 PM EDT | PreveCeutical Medical Inc.
Akanda Corp. Addresses Impacts of Postal Strike on Receiving Materials for Its Upcoming Special Meeting
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that, due to the ongoing postal strike in Canada, the Company is unable to mail shareholder proxy materials (the "Meeting Materials") for its upcoming special meeting (the "Meeting") of shareholders scheduled for 10:00 a.m. (Toronto time) on Thursday, October 30, 2025, at the offices of Gowling WLG (Canada) LLP, Suite 1600, 100
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-10 2:00 PM EDT | Akanda Corp
Konan Medical's objective FIELD(R) Perimeter Obtains CE Mark Under MDR
Irvine, California--(Newsfile Corp. - October 10, 2025) - Konan Medical USA, Inc. today announced its groundbreaking objectiveFIELD Analyzer (OFA®) has received CE Marking under the European Medical Device Regulation (MDR). This significant milestone enables the Company to offer advanced perimetry to healthcare providers across the European Union. Receiving CE Marking signifies that the device meets the stringent safety and performance requirements set forth by the Europ
2025-10-10 9:00 AM EDT | Konan Medical USA Inc.
TempraMed Receives Final Receipt for Prospectus and Closes Reverse Takeover Transaction of TempraMed Israel
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - TempraMed Technologies Ltd. (the "Company") is pleased to announce that the Company has filed and obtained a receipt on September 29, 2025, for its final long form prospectus dated September 25, 2025 (the "Prospectus"), with the British Columbia Securities Commission and is now a reporting issuer in the Province of British Columbia, effective as of September 29, 2025. The Prospectus was filed for, among other thi
Technology, Biotechnology, Pharmaceuticals, Health
2025-10-10 7:00 AM EDT | TempraMed Technologies Ltd
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the appointment of Michael Raimondo, a 30-year veteran in sales and operations in the healthcare industry to its Board of Directors. Michael was part of Therma's advisory Board, previously announced on August 13, 2024. Mr. Raimondo
Technology, Biotechnology, Health
2025-10-10 6:30 AM EDT | Therma Bright Inc.